Retrieve Medical Holdings Inc

As of December 31, 2022, Retrieve Medical Holdings Inc carries a market capitalization of 10.81M, placing it among publicly traded companies globally. Its enterprise value stands at 10.99M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2022, Retrieve Medical Holdings Inc has 391,817.00 shares outstanding.

These figures are as of December 31, 2022.

As of December 31, 2022, Retrieve Medical Holdings Inc maintains a current ratio of 0.15, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -45.24, indicating conservative leverage, while an interest coverage ratio of -8.84 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended December 31, 2022. Return on assets (ROA) is negative at -147.43, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 1.00, a quick read on workforce productivity versus industry peers.

As of the close on October 19, 2026, Retrieve Medical Holdings Inc's stock has declined approximately 31.03% over the past 52 weeks. The 50-day moving average sits at 0.98, while the 200-day moving average is 1.95.

Over the twelve months ended December 31, 2022, Retrieve Medical Holdings Inc generated - - in revenue and converted that into -217,856.00 in net income, yielding earnings per share of -0.55. EBITDA reached -221,651.00, while operating income came in at -221,651.00.

As of December 31, 2022, Retrieve Medical Holdings Inc holds 96,720.00 in cash and equivalents against 273,000.00 in total debt, resulting in a net debt position of 176,280.00. Total book value stands at -603,396.00, with working capital of -603,396.00 providing operational flexibility.

Retrieve Medical Holdings Inc produced -55,834.00 in operating cash flow over the twelve months ended December 31, 2022.

These figures cover the twelve months ended December 31, 2022. Free cash flow yield is negative at -0.51: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 0.32, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Retrieve Medical Holdings Inc shareholders.

Retrieve Medical Holdings Inc's most recent stock split took place on February 15, 2023 with a 200:1 split ratio.

As of December 31, 2022, Retrieve Medical Holdings Inc has an Altman Z-Score of -79.69, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.